EGFR and head and neck squamous cell carcinoma: Epidermal growth factor receptor (EGFR) is an important molecular target for antineoplastic therapy in head and neck squamous cell carcinoma (HNSCC) as it is found to be upregulated and overexpressed in the majority of HNSCCs and is associated with a poor clinical prognosis [1, 2, 3].